Didanosine Alternatives Compared
Didanosine | Descovy | Bictegravir / emtricitabine / tenofovir alafenamide |
|
---|
Didanosine | Descovy (emtricitabine / tenofovir alafenamide) | Bictegravir / emtricitabine / tenofovir alafenamide |
|
|||||||
---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for HIV Infection, Nonoccupational Exposure. didanosine may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Pre-Exposure Prophylaxis, HIV Infection. Descovy may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for HIV Infection. bictegravir / emtricitabine / tenofovir alafenamide may also be used for purposes not listed in this medication guide. |
||||||||
More about Didanosine | More about Descovy (emtricitabine / tenofovir alafenamide) | More about Bictegravir / emtricitabine / tenofovir alafenamide | ||||||||
Ratings & Reviews | ||||||||||
Be the first to share your experience with this drug. |
Descovy has an average rating of 6.9 out of 10 from a total of 16 ratings on Drugs.com. 67% of reviewers reported a positive effect, while 27% reported a negative effect. |
Bictegravir / emtricitabine / tenofovir alafenamide has an average rating of 7.1 out of 10 from a total of 205 ratings on Drugs.com. 58% of reviewers reported a positive effect, while 20% reported a negative effect. |
||||||||
Drug Class | ||||||||||
Side Effects | ||||||||||
See also: didanosine side effects in more detail. |
See also: Descovy side effects in more detail. |
See also: bictegravir / emtricitabine / tenofovir alafenamide side effects in more detail. |
||||||||
Generic Availability | ||||||||||
Lower cost generic |
N/A |
|||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Descovy prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
Dosage Form(s) Available | ||||||||||
|
|
N/A |
||||||||
Brand Names | ||||||||||
N/A |
N/A |
Biktarvy | ||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||
1.5 hours |
25.7 hours |
180 hours |
||||||||
CSA Schedule ** View glossary of terms | ||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category | ||||||||||
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||
Drug Interactions | ||||||||||
A total of 233 drugs are known to interact with didanosine:
|
A total of 234 drugs are known to interact with Descovy:
|
A total of 423 drugs are known to interact with bictegravir / emtricitabine / tenofovir alafenamide:
|
||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
Disease Interactions | ||||||||||
First Approval Date | ||||||||||
N/A |
April 04, 2016 |
February 07, 2018 |
||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||
N/A |
N/A |
N/A |
||||||||
More Information | ||||||||||
Patient resources | ||||||||||
Professional Resources | ||||||||||
Related Treatment Guide | ||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.